| Dr Jeffrey John Roberts, MD | |
|
24723 Detroit Rd, Westlake, OH 44145-2526 | |
| (440) 892-1440 | |
| (440) 892-4709 |
| Full Name | Dr Jeffrey John Roberts |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 39 Years |
| Location | 24723 Detroit Rd, Westlake, Ohio |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679581060 | NPI | - | NPPES |
| 0729868 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35-05-2637-R (Ohio) | Primary |
| 207XS0117X | Orthopaedic Surgery - Orthopaedic Surgery Of The Spine | 35-05-2637-R (Ohio) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Fairview Hospital | Cleveland, OH | Hospital |
| Uh St John Medical Center | Westlake, OH | Hospital |
| University Hospitals Of Cleveland | Cleveland, OH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Orthopaedic Associates, Inc. | 8123915840 | 23 |
News Archive
Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.
Treo Solutions and the Center for Improving Value in Health Care received the 2013 Innovation in Data Dissemination Award from the National Association of Health Data Organizations during its 28th Annual Conference held in Denver, Colorado. The two organizations were recognized for their work creating and evolving the Colorado All Payer Claims Database, designed to provide transparent healthcare price and utilization information to improve care and lower costs.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
› Verified 5 days ago
| Entity Name | Orthopaedic Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912978131 PECOS PAC ID: 8123915840 Enrollment ID: O20040227001003 |
News Archive
Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.
Treo Solutions and the Center for Improving Value in Health Care received the 2013 Innovation in Data Dissemination Award from the National Association of Health Data Organizations during its 28th Annual Conference held in Denver, Colorado. The two organizations were recognized for their work creating and evolving the Colorado All Payer Claims Database, designed to provide transparent healthcare price and utilization information to improve care and lower costs.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
› Verified 5 days ago
| Entity Name | Mercy Health Physicians Lorain Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023347192 PECOS PAC ID: 1355474172 Enrollment ID: O20100730000651 |
News Archive
Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.
Treo Solutions and the Center for Improving Value in Health Care received the 2013 Innovation in Data Dissemination Award from the National Association of Health Data Organizations during its 28th Annual Conference held in Denver, Colorado. The two organizations were recognized for their work creating and evolving the Colorado All Payer Claims Database, designed to provide transparent healthcare price and utilization information to improve care and lower costs.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
› Verified 5 days ago
| Entity Name | Mercy Health Physicians Lorain Specialty Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972126381 PECOS PAC ID: 4688070055 Enrollment ID: O20210909003432 |
News Archive
Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.
Treo Solutions and the Center for Improving Value in Health Care received the 2013 Innovation in Data Dissemination Award from the National Association of Health Data Organizations during its 28th Annual Conference held in Denver, Colorado. The two organizations were recognized for their work creating and evolving the Colorado All Payer Claims Database, designed to provide transparent healthcare price and utilization information to improve care and lower costs.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jeffrey John Roberts, MD 24723 Detroit Rd, Westlake, OH 44145-2526 Ph: (440) 892-1440 | Dr Jeffrey John Roberts, MD 24723 Detroit Rd, Westlake, OH 44145-2526 Ph: (440) 892-1440 |
News Archive
Skilled Healthcare Group, Inc. today announced it has updated its 2010 full year non-GAAP earnings estimates and expects consolidated revenue to be approximately $816 million to $819 million, Adjusted EBITDAR to be approximately $138.9 million to $140.7 million and Adjusted EBITDA to be approximately $119.7 million to $121.5 million. The Company expects adjusted earnings per diluted share for 2010 to be between $1.01 and $1.04.
Treo Solutions and the Center for Improving Value in Health Care received the 2013 Innovation in Data Dissemination Award from the National Association of Health Data Organizations during its 28th Annual Conference held in Denver, Colorado. The two organizations were recognized for their work creating and evolving the Colorado All Payer Claims Database, designed to provide transparent healthcare price and utilization information to improve care and lower costs.
Merck & Co., Inc., which operates outside the U.S. and Canada as MSD, today announced the European Commission (EC) approval of ELONVA® (corifollitropin alfa injection). ELONVA is indicated for controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.
The Drugs for Neglected Diseases initiative (DNDi) has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.
› Verified 5 days ago
Dr. Michael George Hritz, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 Fax: 440-892-4709 | |
Dr. Mehrun Kadkhodai Elyaderani, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 Fax: 440-892-4709 | |
Dr. Duret Stanford Smith, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 Fax: 440-892-4709 | |
Dr. Irwin Michael Mandel, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 Fax: 440-892-4709 | |
Donald Philip Stickney, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25200 Center Ridge Rd Ste 1100, Westlake, OH 44145 Phone: 440-349-7137 | |
Dr. Raymond Louis Horwood, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 Fax: 440-892-4709 | |
Joseph Michael Lowry, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 24723 Detroit Rd, Westlake, OH 44145 Phone: 440-892-1440 |